Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16336656

Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept

Author
HARAOUI, Boulos; KEYSTONE, Edward C; THORNE, J. Carter; POPE, Janet E; CHEN, Isaac; ASARE, Charles G; LEFF, Jonathan A
Amgen Inc., Thousand Oaks, California, United States
Arthritis Program Research Group, Newmarket, United States
Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, United States
Division of Advanced Therapeutics, University of Toronto, Toronto, Canada
St. Joseph's Health Care, London, United Kingdom
Wyeth Pharmaceuticals, Markham, Ontario, Canada
Source

Journal of rheumatology. 2004, Vol 31, Num 12, pp 2356-2359, 4 p ; ref : 16 ref

CODEN
JRHUA9
ISSN
0315-162X
Scientific domain
Rheumatology
Publisher
Journal of Rheumatology Publishing, Toronto, ON
Publication country
Canada
Document type
Article
Language
English
Author keyword
TUMOR NECROSIS FACTOR RHEUMATOID ARTHRITIS ANTIRHEUMATIC AGENTS ETANERCEPT INFLIXIMAB
Keyword (fr)
Adulte Amélioration Américain Antirhumatismal Bras Chronique Echelle d'évaluation Etanercept Facteur nécrose tumorale Facteur soluble Health Assessment Questionnaire Stanford Homme Infliximab Infusion Méthode Polyarthrite rhumatoïde Pronostic Rhumatologie Valeur moyenne Voie souscutanée Traitement alternatif Maladie autoimmune Rhumatisme inflammatoire Système ostéoarticulaire pathologie
Keyword (en)
Adult Improvement American Antirheumatic agent Arm Chronic Evaluation scale Etanercept Tumor necrosis factor Soluble factor Health Assessment Questionnaire Stanford Human Infliximab Infusion Method Rheumatoid arthritis Prognosis Rheumatology Mean value Subcutaneous administration Autoimmune disease Inflammatory joint disease Diseases of the osteoarticular system
Keyword (es)
Adulto Mejora Americano Antireumático Brazo Crónico Escala evaluación Etanercept Factor necrosis tumoral Factor soluble Health Assessment Questionnaire Stanford Hombre Infliximab Infusión Método Poliartritis reumatoidea Pronóstico Reumatología Valor medio Vía subcutánea Enfermedad autoinmune Reumatismo inflamatorio Sistema osteoarticular patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system / 002B15D Inflammatory joint diseases

Discipline
Osteoarticular pathology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
16336656

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web